Brain-derived neurotrophic factor and autism: Maternal and infant peripheral blood levels in the early markers for autism (EMA) study

Autism Research

Volumn 1, Issue 2, 2008, Pages 130-137

  Croen, Lisa A ^a   Goines, Paula ^b   Braunschweig, Daniel ^b   Yolken, Robert ^c   Yoshida, Cathleen K ^a   Grether, Judith K ^d   Fireman, Bruce ^a   Kharrazi, Martin ^d   Hansen, Robin L ^b   De Water, Judy Van ^b  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Autism; BDNF; Biologic markers; Neurotrophin; Prenatal

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR;

ARTICLE; AUTISM; BLOOD; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MALE; MATERNAL AGE; NEWBORN; PREGNANCY; PRENATAL DIAGNOSIS;

AUTISTIC DISORDER; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MATERNAL AGE; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 67650173512     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.14     Document Type: Article

References (23)

1. Aman, M.G. (2005). Treatment planning for patients with autism spectrum disorders. Journal of Clinical Psychiatry, 66, 38-45.
2. Anderson, G.M. (2002). Genetics of childhood disorders: XLV. Autism, part 4: serotonin in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1513-1516.
3. Angelucci, F., Brene, S., and Mathe, A.A. (2005). BDNF in schizophrenia, depression and corresponding animal models. Molecular Psychiatry, 10, 345-352.
4. Binder, D.K., and Scharfman, H.E. (2004). Brain-derived neurotrophic factor. Growth Factors, 22, 123-131.
5. Chakrabarti, S., and Fombonne, E. (2005). Pervasive developmental disorders in preschool children: confirmation of high prevalence. The American Journal of Psychiatry, 162, 1133-1141.
6. Connolly, A.M., Chez, M., Streif, E.M., Keeling, R.M., Golumbek, P.T., et al. (2006). Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biological Psychiatry, 59, 354-363.
7. Enstrom, A., Onore, C., Tarver, A., Hertz-picciotto, I., Hansen, R., et al. (2008). The peripheral blood leukocyte production of BDNF following mitogen stimulation in early onset and regressive autism. American Journal of Biochemistry and Biotechnology, 4, 121-129.
8. Hashimoto, K., Iwata, Y., Nakamura, K., Tsujii, M., Tsuchiya, K.J., et al. (2006). Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Progress in Neuropsychopharmacology and Biological Psychiatry, 30, 1529-1531.
9. Hashimoto, K., Shimizu, E., and Iyo, M. (2004). Critical role of brain-derived neurotrophic factor in mood disorders. Brain Research. Brain Research Reviews, 45, 104-114.
10. Hyman, C., Hofer, M., Barde, Y.A., Juhasz, M., Yancopoulos, G.D., et al. (1991). BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature, 350, 230-232.
11. Karege, F., Schwald, M., and Cisse, M. (2002). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neuroscience Letters, 328, 261-264.
12. Katoh-Semba, R., Wakako, R., Komori, T., Shigemi, H., Miyazaki, N., et al. (2007). Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls. International Journal of Developmental Neuroscience, 25, 367-372.
13. Lommatzsch, M., Hornych, K., Zingler, C., Schuff-Werner, P., Hoppner, J., and Virchow, J.C. (2006). Maternal serum concentrations of BDNF and depression in the perinatal period. Psychoneuroendocrinology, 31, 388-394.
14. Lord, C., Cook, E.H., Leventhal, B.L., and Amaral, D.G. (2000). Autism spectrum disorders. Neuron, 28, 355-363.
15. Miyazaki, K., Narita, N., Sakuta, R., Miyahara, T., Naruse, H., et al. (2004). Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain and Development, 26, 292-295.
16. Nelson, K.B., Grether, J.K., Croen, L.A., Dambrosia, J.M., Dickens, B.F., et al. (2001). Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Annals of Neurology, 49, 597-606.
17. Nelson, P.G., Kuddo, T., Song, E.Y., Dambrosia, J.M., Kohler, S., et al. (2006). Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. International Journal of Developmental Neuroscience, 24, 73-80.
18. Perry, E.K., Lee, M.L., Martin-Ruiz, C.M., Court, JA, Volsen, S.G., et al. (2001). Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. The American Journal of Psychiatry, 158, 1058-1066.
19. Pezet, S., and Malcangio, M. (2004). Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opinion on Therapeutic Targets, 8, 391-399.
20. Tsai, S.J. (2005). Is autism caused by early hyperactivity of brainderived neurotrophic factor? Medical Hypotheses, 65, 79-82.
21. Volkmar, F.R., Lord, C., Bailey, A., Schultz, R.T., and Klin, A. (2004). Autism and pervasive developmental disorders. Journal of Child Psychology and Psychiatry and Allied Disciplines, 45, 135-170.
22. Willemsen-Swinkels, S.H., and Buitelaar, J.K. (2002). The autistic spectrum: subgroups, boundaries, and treatment. The Psychiatric Clinics of North America, 25, 811-836.
23. Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., and Murphy, C. (2003). Prevalence of autism in a US metropolitan area. The Journal of the American Medical Association, 289, 49-55.